Curcumin: Biological activities and modern pharmaceutical forms
M Urošević, L Nikolić, I Gajić, V Nikolić, A Dinić… - Antibiotics, 2022 - mdpi.com
Curcumin (1, 7-bis-(4-hydroxy-3-methoxyphenyl)-hepta-1, 6-diene-3, 5-dione) is a natural
lipophilic polyphenol that exhibits significant pharmacological effects in vitro and in vivo …
lipophilic polyphenol that exhibits significant pharmacological effects in vitro and in vivo …
Role of turmeric and curcumin in prevention and treatment of chronic diseases: Lessons learned from clinical trials
Turmeric (Curcuma longa) has been used for thousands of years for the prevention and
treatment of various chronic diseases. Curcumin is just one of> 200 ingredients in turmeric …
treatment of various chronic diseases. Curcumin is just one of> 200 ingredients in turmeric …
Anti-viral potential and modulation of Nrf2 by curcumin: pharmacological implications
Nuclear factor erythroid 2-related factor 2 (Nrf2) is an essential transcription factor that
maintains the cell's redox balance state and reduces inflammation in different adverse …
maintains the cell's redox balance state and reduces inflammation in different adverse …
[HTML][HTML] Therapeutic potency of curcumin for allergic diseases: A focus on immunomodulatory actions
SM Haftcheshmeh, SR Mirhafez, M Abedi… - Biomedicine & …, 2022 - Elsevier
In light of increasing research evidence on the molecular mechanisms of allergic diseases,
the crucial roles of innate and acquired immunity in the disease's pathogenesis have been …
the crucial roles of innate and acquired immunity in the disease's pathogenesis have been …
Antiviral therapeutic potential of curcumin: an update
A Ardebili, MH Pouriayevali, S Aleshikh, M Zahani… - Molecules, 2021 - mdpi.com
The treatment of viral disease has become a medical challenge because of the increasing
incidence and prevalence of human viral pathogens, as well as the lack of viable treatment …
incidence and prevalence of human viral pathogens, as well as the lack of viable treatment …
An overview of the therapeutic effects of curcumin in reproductive disorders with a focus on the antiinflammatory and immunomodulatory activities
B Saifi, SM Haftcheshmeh, M Feligioni… - Phytotherapy …, 2022 - Wiley Online Library
Curcumin, the polyphenolic compound obtained from turmeric, has several pharmacological
properties. These properties include antioxidant, antimicrobial, anti‐angiogenic …
properties. These properties include antioxidant, antimicrobial, anti‐angiogenic …
Curcumin: a dietary phytochemical for targeting the phenotype and function of dendritic cells
K Rahimi, K Hassanzadeh… - Current medicinal …, 2021 - ingentaconnect.com
Dendritic cells (DCs) are the most powerful antigen-presenting cells which link the innate
and adaptive immune responses. Depending on the context, DCs initiate the immune …
and adaptive immune responses. Depending on the context, DCs initiate the immune …
Curcumin: A therapeutic strategy for targeting the Helicobacter pylori-related diseases
Helicobacter pylori is a significant human pathogen of the stomach's epithelial lining. This
type of carcinogen is associated with gastric cancer, indigestion, peptic ulcers, and upper …
type of carcinogen is associated with gastric cancer, indigestion, peptic ulcers, and upper …
The role of curcumin in the liver-gut system diseases: from mechanisms to clinical therapeutic perspective
T Qin, X Chen, J Meng, Q Guo, S Xu… - Critical Reviews in …, 2023 - Taylor & Francis
Natural products have provided abundant sources of lead compounds for new drug
discovery and development over the past centuries. Curcumin is a lipophilic polyphenol …
discovery and development over the past centuries. Curcumin is a lipophilic polyphenol …
Advances in the treatment of human T-cell lymphotropic virus type-I associated myelopathy
ABSTRACT Introduction Nearly 2–3% of those 10 to 20 million individuals infected with the
Human T-cell lymphotropic virus type-1 (HTLV-1); are predisposed to developing HTLV-1 …
Human T-cell lymphotropic virus type-1 (HTLV-1); are predisposed to developing HTLV-1 …